Harnessing the potential synergy of combining radiation therapy and immunotherapy for thoracic malignancies.
作者信息
Simone Charles B, Berman Abigail T, Jabbour Salma K
机构信息
Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA. (Email:
Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. (Email:
出版信息
Transl Lung Cancer Res. 2017 Apr;6(2):109-112. doi: 10.21037/tlcr.2017.04.05.
Abstract
摘要
相似文献
1
Harnessing the potential synergy of combining radiation therapy and immunotherapy for thoracic malignancies.利用放射治疗和免疫治疗联合治疗胸部恶性肿瘤的潜在协同作用。
Transl Lung Cancer Res. 2017 Apr;6(2):109-112. doi: 10.21037/tlcr.2017.04.05.
2
Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies.免疫治疗联合放疗治疗泌尿生殖系统恶性肿瘤。
Eur Urol Oncol. 2019 Feb;2(1):79-87. doi: 10.1016/j.euo.2018.09.013. Epub 2018 Nov 16.
3
The synergy between ionizing radiation and immunotherapy in the treatment of prostate cancer.电离辐射与免疫疗法在前列腺癌治疗中的协同作用。
Immunotherapy. 2017 Sep;9(12):1005-1018. doi: 10.2217/imt-2017-0051.
4
Immunotherapy and Radiation - A New Combined Treatment Approach for Bladder Cancer?免疫疗法与放疗——膀胱癌的一种新的联合治疗方法？
Bladder Cancer. 2015 Apr 30;1(1):15-27. doi: 10.3233/BLC-150014.
5
[Combining radiotherapy with immunotherapy for urological malignancies].[放射治疗与免疫治疗联合用于泌尿生殖系统恶性肿瘤]
Urologe A. 2018 Nov;57(11):1309-1315. doi: 10.1007/s00120-018-0789-x.
6
Combining immunotherapy and radiotherapy in lung cancer.肺癌中免疫疗法与放射疗法的联合应用。
J Thorac Dis. 2018 May;10(Suppl 13):S1447-S1460. doi: 10.21037/jtd.2018.05.107.
7
Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy.放疗与免疫检查点抑制剂治疗：增敏作用及协同作用的潜在机制。
Lancet Oncol. 2015 Oct;16(13):e498-509. doi: 10.1016/S1470-2045(15)00007-8.
8
Combining stereotactic body radiation therapy with immunotherapy: current data and future directions.立体定向体部放射治疗与免疫治疗相结合：当前数据与未来方向。
Transl Lung Cancer Res. 2019 Feb;8(1):107-115. doi: 10.21037/tlcr.2018.08.16.
9
Immunotherapy and Radiation: Charting a Path Forward Together.免疫疗法与放射治疗：携手前行的路径
Hematol Oncol Clin North Am. 2019 Dec;33(6):1057-1069. doi: 10.1016/j.hoc.2019.08.001. Epub 2019 Sep 17.
10
Immunotherapy and radiation therapy: considerations for successfully combining radiation into the paradigm of immuno-oncology drug development.免疫疗法和放射疗法：将放射疗法成功结合到免疫肿瘤学药物开发范例中的考虑因素。
Radiat Res. 2014 Aug;182(2):252-7. doi: 10.1667/RR13707.1. Epub 2014 Jul 8.
引用本文的文献
1
The utilization of immunotherapy with radiation therapy in lung cancer: a narrative review.肺癌中免疫疗法与放射疗法的联合应用：一篇叙述性综述。
Transl Cancer Res. 2021 May;10(5):2596-2608. doi: 10.21037/tcr-20-2241.
2
Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research.小细胞肺癌：从传统疗法到创新疗法——构建优化临床与转化研究的综合网络
J Clin Med. 2020 Jul 30;9(8):2433. doi: 10.3390/jcm9082433.
3
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.帕博利珠单抗联合同步放化疗治疗局部晚期非小细胞肺癌的 1 期临床试验：一项非随机对照试验。
JAMA Oncol. 2020 Jun 1;6(6):848-855. doi: 10.1001/jamaoncol.2019.6731.
4
The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature.免疫疗法在广泛期小细胞肺癌中的作用：文献综述
Can Respir J. 2019 Nov 3;2019:6860432. doi: 10.1155/2019/6860432. eCollection 2019.
5
Approaches to stereotactic body radiation therapy for large (≥5 centimeter) non-small cell lung cancer.大型（≥5厘米）非小细胞肺癌的立体定向体部放射治疗方法
Transl Lung Cancer Res. 2019 Feb;8(1):70-77. doi: 10.21037/tlcr.2018.06.10.
6
Advances in radiation therapy for thoracic malignancies.胸部恶性肿瘤放射治疗的进展
J Thorac Dis. 2018 Aug;10(Suppl 21):S2431-S2436. doi: 10.21037/jtd.2018.08.10.
7
Proton therapy for small cell lung cancer.小细胞肺癌的质子治疗。
Transl Lung Cancer Res. 2018 Apr;7(2):134-140. doi: 10.21037/tlcr.2018.04.02.
本文引用的文献
1
Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.帕博利珠单抗治疗恶性胸膜间皮瘤患者的临床安全性和疗效（KEYNOTE-028）：一项非随机、开放标签、Ib 期试验的初步结果。
Lancet Oncol. 2017 May;18(5):623-630. doi: 10.1016/S1470-2045(17)30169-9. Epub 2017 Mar 11.
2
The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma.胸腺瘤和胸腺癌术后放疗的影响。
J Thorac Oncol. 2017 Apr;12(4):734-744. doi: 10.1016/j.jtho.2017.01.002. Epub 2017 Jan 25.
3
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.调强放射治疗技术对局部晚期非小细胞肺癌的影响：NRG肿瘤学RTOG 0617随机临床试验的二次分析
J Clin Oncol. 2017 Jan;35(1):56-62. doi: 10.1200/JCO.2016.69.1378. Epub 2016 Oct 31.
4
National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer.非小细胞肺癌中质子放疗与光子放疗的国家癌症数据库分析
Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):128-137. doi: 10.1016/j.ijrobp.2016.10.001. Epub 2016 Oct 11.
5
Modern radiotherapy using image guidance for unresectable non-small cell lung cancer can improve outcomes in patients treated with chemoradiation therapy.采用图像引导的现代放射疗法用于不可切除的非小细胞肺癌，可改善接受放化疗患者的治疗效果。
J Thorac Dis. 2016 Sep;8(9):2602-2609. doi: 10.21037/jtd.2016.08.95.
6
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.帕博利珠单抗对比化疗用于 PD-L1 阳性非小细胞肺癌。
N Engl J Med. 2016 Nov 10;375(19):1823-1833. doi: 10.1056/NEJMoa1606774. Epub 2016 Oct 8.
7
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.三期随机临床试验：伊匹单抗联合依托泊苷和铂类药物与安慰剂联合依托泊苷和铂类药物治疗广泛期小细胞肺癌。
J Clin Oncol. 2016 Nov 1;34(31):3740-3748. doi: 10.1200/JCO.2016.67.6601.
8
First Clinical Investigation of Cone Beam Computed Tomography and Deformable Registration for Adaptive Proton Therapy for Lung Cancer.首次临床研究：锥形束计算机断层扫描和形变配准在肺癌自适应质子治疗中的应用。
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):549-559. doi: 10.1016/j.ijrobp.2016.01.055. Epub 2016 Feb 4.
9
Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.早期和局部晚期非小细胞肺癌质子治疗共识声明
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):505-516. doi: 10.1016/j.ijrobp.2016.01.036. Epub 2016 Jan 23.
10
Risk factors and management of oligometastatic non-small cell lung cancer.寡转移非小细胞肺癌的危险因素与管理
Ther Adv Respir Dis. 2016 Aug;10(4):338-48. doi: 10.1177/1753465816642636. Epub 2016 Apr 8.
Zotero 插件